C3 glomerulopathy: consensus report
Matthew Caleb Pickering, Vivette Denise D’Agati, Carla Nester et al. · Kidney International · 2013
C3 glomerulopathy is a recently introduced pathological entity whose original definition was glomerular pathology characterized by C3 accumulation with absent or scanty immunoglobulin deposition. In August 2012, an invited group of experts (comprising the authors of this document) in renal pathology, nephrology, complement biology, and complement therapeutics met to discuss C3 glomerulopathy in the first C3 Glomerulopathy Meeting. The objectives were to reach a consensus on: the definition of C3 glomerulopathy, appropriate complement investigations that should be performed in these patients, and how complement therapeutics should be explored in the condition. This meeting report represents the current consensus view of the group.
Cited by 653 works. doi:10.1038/ki.2013.377 Open-access PDF
Authors
- Matthew Caleb Pickering
- Vivette Denise D’Agati
- Carla Nester
- Richard J. Smith
- Mark Haas
- Gerald B. Appel
- Charles E. Alpers
- Ingeborg M. Bajema
- Camille L. Bedrosian
- Michael Braun
- Mittie K. Doyle
- Fádi Fakhouri
- Fernando Custodio Fervenza
- Agnes B. Fogo
- Véronique Frémeaux‐Bacchi
- Daniel Philip Gale
- Elena Goicoechea de Jorge
- Claire Louise Harris
- Vernon Michael Holers
References
- The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification
- Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease)
- Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies
- C3 glomerulopathy: a new classification
- Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis
- Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis
- Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H.
- Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement
- Membranoproliferative Glomerulonephritis Secondary to Monoclonal Gammopathy
- Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation